{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2018", "item": "https://www.patentleaderboard.com/2018/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2018/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Patrick Robert Verhoest", "item": "https://www.patentleaderboard.com/2018/inventor/fl:pa_ln:verhoest-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PV

Patrick Robert Verhoest — 4 Patents in 2018

Pfizer: 4 patents #5 of 317Top 2%
Newton, MA: #46 of 511 inventorsTop 10%
Massachusetts: #807 of 12,682 inventorsTop 7%
Overall (2018): #38,081 of 503,207Top 8%
4 Patents 2018

Issued Patents 2018

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10131669 Pyrazolopyrimidine compounds Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal, Simone Sciabola +3 more 2018-11-20 $851,493,000
10112958 N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Peter Mikochik +2 more 2018-10-30 $721,374,000
10077269 Imidazopyridazine compounds Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal, Simone Sciabola +2 more 2018-09-18 $396,134,000
10039753 Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors Karen Coffman, Paul Galatsis, Michelle Renee Garnsey, Jaclyn Louise Henderson, Bethany Lyn Kormos +5 more 2018-08-07 $243,216,000